Vaccitech COO Chris Ellis announces retirement effective Oct 31, 2023

Barinthus Biotherapeutics plc.

Chris Ellis, Chief Operating Officer (principal operating officer), informed company of retirement on April 24, 2023.
Retirement effective October 31, 2023; no replacement named.
Mr. Ellis's departure is a planned retirement, not an immediate resignation.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Chris Ellis

Chief Operating Officer

BRNS · Barinthus Biotherapeutics plc.

Effective: 2023-10-31
Filed: April 28, 2023, 7:59 PM ET

On April 24, 2023, Chris Ellis, our Chief Operating Officer (principal operating officer), informed Vaccitech plc (the “Company”) of his retirement from the Company, effective October 31, 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Chris Ellis retired as Chief Operating Officer at Barinthus Biotherapeutics plc..

Action: retired
Role: Chief Operating Officer

Exact text from the filing

On April 24, 2023, Chris Ellis, our Chief Operating Officer (principal operating officer), informed Vaccitech plc (the “Company”) of his retirement from the Company, effective October 31, 2023.

View on SEC.gov

Barinthus Biotherapeutics plc. filing history →

Source: SEC EDGAR

accession 0001104659-23-052906

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.